Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01860885 · ClinicalTrials.gov registry record

Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure

A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
95
Enrollment target

NCT01860885 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 95 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01860885 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
95 participants
Enrollment target

Study Summary

Opioids are the mainstay of analgesia in hospitalized children but opioid therapy is associated with life-threatening respiratory depression requiring antagonism with naloxone. Hence, it is hypothesized that naloxone requirement can be used as a quality measure of opioid safety. A retrospective medical chart review of 95 patients, who received naloxone for life threatening events, from June 2006-2012, is planned, to identify significant factors associated with risk for opioid induced respiratory depression and formulation of preventive strategies.

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2012-08
Est. Completion 2013-05

What the Registry Record Tells You About NCT01860885

The ClinicalTrials.gov registry entry for NCT01860885 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01860885 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01860885 about?

NCT01860885 is a clinical study titled "Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure". Opioids are the mainstay of analgesia in hospitalized children but opioid therapy is associated with life-threatening respiratory depression requiring antagonism with naloxone. Hence, it is hypothesized that naloxone requirement can be used as a quality measure of opioid safety. A retrospective medi...

What is the current status of trial NCT01860885?

This trial is currently completed. The enrollment target is 95 participants. The study started on 2012-08. Estimated completion is 2013-05.

Who is sponsoring clinical trial NCT01860885?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.